NL150440B - Werkwijze voor het bereiden van een geneesmiddel met serumlipiden verlagende en vaatverwijdende eigenschappen dat een 3-pyridylmethanolderivaat bevat en de onder toepassing van deze werkwijze verkregen gevormde geneesmiddelen met deze eigenschappen, alsmede werkwijze voor het bereiden van dergelijke geneeskrachtige 3-pyridylmethanolderivaten. - Google Patents

Werkwijze voor het bereiden van een geneesmiddel met serumlipiden verlagende en vaatverwijdende eigenschappen dat een 3-pyridylmethanolderivaat bevat en de onder toepassing van deze werkwijze verkregen gevormde geneesmiddelen met deze eigenschappen, alsmede werkwijze voor het bereiden van dergelijke geneeskrachtige 3-pyridylmethanolderivaten.

Info

Publication number
NL150440B
NL150440B NL676715616A NL6715616A NL150440B NL 150440 B NL150440 B NL 150440B NL 676715616 A NL676715616 A NL 676715616A NL 6715616 A NL6715616 A NL 6715616A NL 150440 B NL150440 B NL 150440B
Authority
NL
Netherlands
Prior art keywords
properties
pyridylmethanolderivaten
pyridylmethanolderivaat
medicinal
drug
Prior art date
Application number
NL676715616A
Other languages
English (en)
Dutch (nl)
Other versions
NL6715616A (no
Original Assignee
Astra Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE15717/66A external-priority patent/SE327987B/xx
Application filed by Astra Ab filed Critical Astra Ab
Publication of NL6715616A publication Critical patent/NL6715616A/xx
Publication of NL150440B publication Critical patent/NL150440B/xx
Priority to NL7610725A priority Critical patent/NL7610725A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
    • C07D213/30—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/455—Nicotinic acids, e.g. niacin; Derivatives thereof, e.g. esters, amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/40—Acylated substituent nitrogen atom
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/54—Radicals substituted by carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/55—Acids; Esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/73—Unsubstituted amino or imino radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • C07D213/80—Acids; Esters in position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/89—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to the ring nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Purses, Travelling Bags, Baskets, Or Suitcases (AREA)
NL676715616A 1966-11-16 1967-11-16 Werkwijze voor het bereiden van een geneesmiddel met serumlipiden verlagende en vaatverwijdende eigenschappen dat een 3-pyridylmethanolderivaat bevat en de onder toepassing van deze werkwijze verkregen gevormde geneesmiddelen met deze eigenschappen, alsmede werkwijze voor het bereiden van dergelijke geneeskrachtige 3-pyridylmethanolderivaten. NL150440B (nl)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NL7610725A NL7610725A (en) 1966-11-16 1976-09-28 Fluoro nicotinate ester medicaments - with hypolipaemic and vasodilatory activity

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE15717/66A SE327987B (no) 1966-11-16 1966-11-16
GB03687/67A GB1213162A (en) 1966-11-16 1967-03-23 Serum lipid lowering pyridine derivatives and their preparation
GB19174/67A GB1157186A (en) 1966-11-16 1967-04-26 Serum Lipid Lowering Pyridine Derivatives

Publications (2)

Publication Number Publication Date
NL6715616A NL6715616A (no) 1968-05-17
NL150440B true NL150440B (nl) 1976-08-16

Family

ID=27257023

Family Applications (2)

Application Number Title Priority Date Filing Date
NL676715616A NL150440B (nl) 1966-11-16 1967-11-16 Werkwijze voor het bereiden van een geneesmiddel met serumlipiden verlagende en vaatverwijdende eigenschappen dat een 3-pyridylmethanolderivaat bevat en de onder toepassing van deze werkwijze verkregen gevormde geneesmiddelen met deze eigenschappen, alsmede werkwijze voor het bereiden van dergelijke geneeskrachtige 3-pyridylmethanolderivaten.
NL6904594A NL6904594A (no) 1966-11-16 1969-03-25

Family Applications After (1)

Application Number Title Priority Date Filing Date
NL6904594A NL6904594A (no) 1966-11-16 1969-03-25

Country Status (15)

Country Link
US (2) US3637714A (no)
JP (1) JPS5023030B1 (no)
AT (2) AT289113B (no)
BE (1) BE706471A (no)
CH (1) CH508625A (no)
DE (3) DE1670003B2 (no)
DK (1) DK125709B (no)
ES (1) ES347190A1 (no)
FI (1) FI49962C (no)
FR (3) FR8017M (no)
GB (3) GB1213162A (no)
IE (1) IE32127B1 (no)
NL (2) NL150440B (no)
NO (1) NO124927B (no)
SE (1) SE364510B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3737542A (en) * 1966-11-16 1973-06-05 Lars Anders Fritz Carlsson Lowering excessive serum lipid concentrations and preparations containing fluoro-pyridine derivatives
GB1312775A (en) * 1969-07-07 1973-04-04 Mar Pha Etu Expl Marques Aryloxyalkyl nicotinates
FR2074707B1 (no) * 1970-01-20 1973-01-12 Centre Etd Ind Pharma
US4115393A (en) * 1974-03-28 1978-09-19 Siegfried Aktiengesellschaft Pyridyl alkyl esters of substituted phenoxy alkanoic acids having the ability to reduce the level of fatty substances in the blood
FR2270878B1 (no) * 1974-05-15 1978-02-03 Fabre Sa Pierre
DE2443539C3 (de) * 1974-09-11 1978-11-23 Karl Dr.Med. 4044 Kaarst Credner Ester der 5-n-Butyl-pyridin-carbonsäure- (2), Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende Arzneipräparate
BE826867A (fr) * 1974-11-20 1975-07-16 Medicament hypolipidemiant et hydrocholesterolemiant
US4058534A (en) * 1975-03-14 1977-11-15 Solco Basel Ag Therapeutically effective nicotinates and N-oxide nicotinates of aliphatic amines
ES438245A1 (es) * 1975-06-04 1977-01-16 Alter Sa Procedimiento de purificacion del ester mixto 1-(2-(p-cloro-fenoxi)-2metilpropionato), 2-nicotinato de etilenglicol.
ES438246A1 (es) * 1975-06-04 1977-01-16 Alter Sa Un procedimiento de preparacion del glicol 2-(p-clorofenoci)-2-metilpropinato nicotinato.
JPS5387531A (en) * 1977-01-11 1978-08-02 Takenaka Komuten Co Foldable hanging scaffold for building
JPS53101827A (en) * 1977-02-17 1978-09-05 Takenaka Komuten Co Method of temporarily building scaffold
JPS5422927A (en) * 1977-07-22 1979-02-21 Takenaka Komuten Co Method of tentatively building scaffold* and scaffold for effecting said method
DE2962915D1 (en) * 1979-11-02 1982-07-08 Stauffer Chemical Co Pyridylalkyl esters, insect repellent compositions and method of repelling insects
IT1168389B (it) * 1981-05-06 1987-05-20 Alfa Farmaceutici Spa Derivati di alcandioli con attivita' ipolipidemizzante,metodi per la loro preparazione e composizioni farmaceutiche che li contengono
DE3315877A1 (de) * 1983-05-02 1984-11-08 Merz + Co GmbH & Co, 6000 Frankfurt N-oxide von pyridyl-carbonsaeureestern, ein verfahren zu ihrer herstellung und pharmazeutische mittel, die diese verbindungen enthalten
AT383346B (de) * 1983-05-02 1987-06-25 Merz & Co Gmbh & Co Verfahren zur herstellung von neuen n-oxiden von pyridylcarbonsaeureestern
FR2612189B1 (fr) * 1987-03-13 1989-06-23 Roussel Uclaf Nouveaux derives de la pyridine, leur procede de preparation et les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions les renfermant
LU87821A1 (fr) * 1990-10-12 1992-05-25 Cird Galderma Composes bi-aromatiques,et leur utilisation en medecine humaine et veterinaire et en cosmetique
US5436344A (en) * 1990-11-29 1995-07-25 Pfizer Inc. 3-bromo-5-chloro-pyridines used as intermediates in the synthesis of azatetralones
WO1993011768A1 (en) * 1991-12-13 1993-06-24 Smithkline Beecham Corporation Pyridyl compounds for psoriasis treatment
ATE429915T1 (de) * 2002-10-10 2009-05-15 Arena Pharm Inc 5-substituierte 2h-pyrazon-3-carbonsäure-derivate als antilipolytische mittel zur behandlung von stoffwechselstörungen, wie z.b. dyslipidemie
AU2004260636A1 (en) * 2003-06-13 2005-02-10 Arena Pharmaceuticals, Inc. 5-substituted 2H-pyrazole-3-carboxylic acid derivatives as agonists for the nicotinic acid receptor RUP25 for the treatment of dyslipidemia and related diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE322214B (no) * 1965-06-28 1970-04-06 Bofors Ab
FR1498459A (no) * 1965-07-30 1968-01-08

Also Published As

Publication number Publication date
IE32127B1 (en) 1973-04-18
SE364510B (no) 1974-02-25
FR1544594A (fr) 1968-10-31
BE706471A (no) 1968-05-14
JPS5023030B1 (no) 1975-08-05
CH508625A (de) 1971-06-15
DE1670003A1 (de) 1971-11-04
IE32127L (en) 1968-10-26
US3622587A (en) 1971-11-23
DK125709B (da) 1973-03-26
AT289113B (de) 1971-04-13
DE1912352B2 (de) 1975-04-17
DE1795792B2 (de) 1979-07-19
NL6904594A (no) 1969-09-29
ES347190A1 (es) 1969-05-01
AT294089B (de) 1971-11-10
FI49962B (no) 1975-07-31
FR8017M (no) 1970-08-03
GB1213162A (en) 1970-11-18
DE1795792A1 (de) 1975-06-19
DE1670003B2 (de) 1976-06-16
DE1795792C3 (de) 1980-03-20
GB1171509A (en) 1969-11-19
GB1157186A (en) 1969-07-02
FI49962C (fi) 1975-11-10
US3637714A (en) 1972-01-25
DE1912352A1 (de) 1969-10-09
FR2004661A1 (no) 1969-11-28
NO124927B (no) 1972-06-26
DE1912352C3 (de) 1975-11-27
NL6715616A (no) 1968-05-17

Similar Documents

Publication Publication Date Title
NL150440B (nl) Werkwijze voor het bereiden van een geneesmiddel met serumlipiden verlagende en vaatverwijdende eigenschappen dat een 3-pyridylmethanolderivaat bevat en de onder toepassing van deze werkwijze verkregen gevormde geneesmiddelen met deze eigenschappen, alsmede werkwijze voor het bereiden van dergelijke geneeskrachtige 3-pyridylmethanolderivaten.
NL166399C (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat met anti-inflammatoire werking, de onder toepassing daarvan verkregen gevormde geneesmiddelen, alsmede werkwijze ter bereiding van anti-inflammatoir werkzame heterocyclische verbindingen.
NL170535C (nl) Werkwijze voor het bereiden van asymmetrische 1.4-dihydropyridine 3.5-dicarbonzuuresters, alsmede voor het bereiden van farmaceutische preparaten en de onder toepassing daarvan verkregen gevormde voortbrengselen.
NL171444C (nl) Werkwijze voor de bereiding van 1,2,3,4-tetrahydro-4-fenylisochinolinederivaten, alsmede werkwijze voor de bereiding van farmaceutische preparaten met antidepressieve eigenschappen, die deze derivaten bevatten.
NL148312B (nl) Werkwijze voor het bereiden van een geneesmiddel dat een of een aantal 1-chinolyl-2-alkylaminoethanolderivaten en/of de zuuradditiezouten daarvan bevat en de onder toepassing van deze werkwijze verkregen gevormde geneesmiddelen, alsmede werkwijze voor het bereiden van deze geneeskrachtige derivaten en de zuuradditiezouten daarvan.
NL172653C (nl) Werkwijze voor het bereiden van een geneesmiddel met antimycotische werking en werkwijze voor het bereiden van geneeskrachtige joodpropargyloxyareenderivaten.
NL7711993A (nl) Werkwijze voor het bereiden van een geneesmiddel van hypoglycemische werking, alsmede het verkregen gevormde geneesmiddel.
NL186383C (nl) Werkwijze voor de bereiding van octahydroindolochinolizinederivaten en werkwijze voor de bereiding van een farmaceutisch preparaat met vaatverwijdende werking, alsmede gevormd farmaceutisch preparaat.
NL152171B (nl) Werkwijze voor het bereiden van een geneesmiddel met vaatverwijdende eigenschappen, alsmede gevormd geneesmiddel.
NL163720C (nl) Verbetering van de werkwijze voor het bereiden van een injecteerbaar proteineprodukt, alsmede werkwijze voor het bereiden van een injecteerbaar geneesmiddel en gevormde geneesmiddelen.
NL7608810A (nl) Werkwijze voor het bereiden van pyrazool-deri- vaten en werkwijze voor het bereiden van een geneesmiddel met anti-inflammatorische werking.
NL162385B (nl) Werkwijze voor het bereiden van een farmaceutisch preparaat met perifere en cerebrale vasodilatoire werking, onder toepassing daarvan verkregen gevormd preparaat en werkwijze voor het bereiden van een verbinding met de aangegeven werking.
NL152859B (nl) Werkwijze voor het bereiden van een geneesmiddel tegen hartkwalen en het verkregen gevormde geneesmiddel, alsmede werkwijze voor het bereiden van een voor opnemen in zo'n geneesmiddel geschikt 1-amino-3-chromanyloxy-2-propanolderivaat.
NL7312032A (nl) Werkwijze voor het bereiden en toedienen van een diergeneesmiddel.
NL175418C (nl) Werkwijze voor het bereiden of vervaardigen van een farmaceutisch preparaat met een sedatieve, anxiolitische en krampbestrijdende werking dat een gesubstitueerd ethylaminederivaat bevat, de onder toepassing van deze werkwijze verkregen gevormde preparaten en werkwijze voor het bereiden van de toegepaste gesubstitueerde ethylaminederivaten.
NL7408875A (nl) Werkwijze voor de bereiding van alkalipolyfos- faatcomplexen met antibiotische werking, werk- wijze voor de bereiding van een geneesmiddel met een dergelijke werking en een dergelijk geneesmiddel.
NL154218B (nl) Werkwijze ter bereiding van een geneesmiddel met progestatieve werking, onder toepassing hiervan gevormde geneesmiddelen en werkwijze ter bereiding van de hiertoe geschikte geneeskrachtige 16-methyleen-progesteronderivaten.
NL174042C (nl) Werkwijze voor het bereiden van farmaceutische preparaten op basis van een 5-gesubstitueerd-5-fenylalkylbarbituurzuurderivaat, alsmede werkwijze voor het bereiden van 5-gesubstitueerde-5-fenylalkylbarbituurzuurderivaten, geschikt voor gebruik in dergelijke preparaten.
NL138919B (nl) Werkwijze voor de bereiding van een geneesmiddel en van een geneeskrachtige verbinding.
NL157314B (nl) Werkwijze voor het bereiden van een 3-oxo-13beta-r-17alfa-x, 17beta-hydroxy-gona-4,9,11-trieen, alsmede werkwijze voor het bereiden van een geneesmiddel en onder toepassing daarvan verkregen gevormd geneesmiddel.
NL173957C (nl) Werkwijze voor de bereiding van verbindingen met analgetische en anti-inflammatoire werking en werkwijze voor de bereiding van farmaceutische preparaten die ze bevatten.
NL144923B (nl) Werkwijze voor de bereiding van een nalfa-gesubstitueerd 2-0-methyloxytocinederivaat, werkwijze ter bereiding van farmaceutische preparaten en gevormde preparaten.
NL142403B (nl) Werkwijze ter bereiding van een farmaceutisch preparaat werkzaam tegen leverziekte, gevormd preparaat onder toepassing van deze werkwijze bereid, en werkwijze ter bereiding van de actieve component van het desbetreffende geneesmiddel.
NL140857B (nl) Werkwijze voor de bereiding van een papaverinederivaat met geneeskrachtige werking, werkwijze voor de bereiding van een geneesmiddel, alsmede gevormd geneesmiddel.
NL168843C (nl) Werkwijze voor het bereiden van een ontstekingsremmend geneesmiddel dat een 17,21-dioxyalkylideenderivaat van een 4-pregneen-3,20-dion bevat en de onder toepassing van deze werkwijze verkregen gevormde geneesmiddelen en werkwijze voor het bereiden van deze 4-pregneen-3,20-dion derivaten.

Legal Events

Date Code Title Description
VJC Lapsed due to non-payment of the due maintenance fee for the patent or patent application
NL80 Information provided on patent owner name for an already discontinued patent

Owner name: ASTRA